2-chloro-3--deoxyadenosine has been researched along with Histiocytosis--Sinus* in 1 studies
1 other study(ies) available for 2-chloro-3--deoxyadenosine and Histiocytosis--Sinus
Article | Year |
---|---|
Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment.
Rosai-Dorfman disease (RDD) or "sinus histiocytosis with massive lymphadenopathy" is a rare lymphoproliferative disorder of unknown etiology. The disease usually presents with painless lymphadenopathy with occasional extranodal involvement in various organs. We report a case of a 36-year-old man with a history of non-Hodgkin lymphoma (NHL), who recently presented with inguinal lymphadenopathy. Following the diagnosis of RDD on lymph node biopsy, he developed symptoms of spinal cord compression due to a mass lesion discovered at T6-7 vertebral level. 18F-Fluorodeoxyglucose (18FDG) positron emission tomography (PET-CT) revealed extensive disease with lung, renal and bone involvement. The patient received a short course of steroid therapy for cord compression findings and 2-chlorodeoxyadenosine (2-CdA) treatment was initiated for long-term disease control. He had a dramatic sustained response to treatment with six courses of 2-CdA. These results suggest that 2-CdA can be an effective treatment of choice and positron emission tomography with 18FDG can be used for determining the extent of disease and for follow-up in RDD. Topics: 2-Chloroadenosine; Adult; Deoxyadenosines; Histiocytosis, Sinus; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Male; Remission Induction; Spinal Cord Compression | 2009 |